10-16
Moleculin anuncia una división inversa de acciones de 1 por 20
Moleculin Biotech presentó una enmienda ante el secretario de Estado de Delaware para ejecutar una división inversa de acciones ordinarias de 1 por 20. La operación entrará en vigor a las 12:01 a. m. (hora del Este) del 20 de octubre de 2026. Con la división, cada 20 acciones ordinarias en circulación se consolidarán en una, y las acciones en circulación pasarán de aproximadamente 20,9 millones a alrededor de 1,05 millones. El capital autorizado se mantendrá en 500 millones de acciones y el título continuará cotizando en el Nasdaq Capital Market.
10-16
10-16
Alector fija en 2,05 dólares por acción una oferta suscrita de 36.600.000 acciones
Alector ha fijado en 2,05 dólares por acción el precio de una oferta suscrita de 36.600.000 acciones ordinarias, lo que supone una prima de aproximadamente el 7,3% sobre el cierre del 15 de octubre. Se prevé que la operación reporte a la compañía unos ingresos brutos de 75.030.000 dólares antes de deducir los descuentos y comisiones de suscripción. La compañía, centrada en el desarrollo de terapias contra enfermedades neurodegenerativas, presentará el correspondiente suplemento del folleto ante la SEC estadounidense.
10-16
10-14
Fusion Fuel Posts First-Half 2026 Results, Expects 11%–25% Full-Year Revenue Growth
Fusion Fuel reported its first-half 2026 results and guided to full-year revenue of €16 million to €18 million, an increase of 11%–25% year over year. Its non-IFRS adjusted operating loss narrowed by about 25% to roughly €1.8 million. In July the company completed its acquisition of Royal Uranium, adding interests in uranium and natural gas project areas. Its BrightHy Solutions unit started a 2 MW industrial green hydrogen project in Spain and contributed about €369,000 in engineering revenue during the half.
10-14
10-13
Cygnus Metals Limited: Kazakhstan regulatory approval received
TORONTO and PERTH, Western Australia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX:CY5, TSXV:CYG, OTCQB:CYGGF) ('Cygnus” or the 'Company”) provides the following update in relation to the proposed transaction under which Central Asia Metals PLC (AIM:CAML) ('CAML”) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) ('Scheme”).
10-13
10-13
Ollie's Bargain Outlet Board Approves $500 Million Share Repurchase Authorization
Ollie's Bargain Outlet Holdings' board of directors unanimously approved a new $500 million share repurchase authorization. Combined with its existing authorization, the company now has approximately $561 million in aggregate repurchase capacity. Since launching its buyback program in 2019, the retailer has returned roughly $679 million to shareholders. It has also continued to invest in new stores, supply chain capacity and strategic growth initiatives.
10-13